A state proposal to limit the number of drugs covered by Medicaid, fiercely opposed by patients and drug companies, has drawn national attention as states struggle to pay for costly new medicines.
from NYT > Politics https://ift.tt/2Japsyq
via IFTTT
from NYT > Politics https://ift.tt/2Japsyq
via IFTTT
Комментариев нет:
Отправить комментарий